BioCardia (BCDA) Accumulated Expenses (2015 - 2026)

BioCardia (BCDA) has reported Accumulated Expenses for 12 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses fell 38.86% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $1.2 million, a 38.86% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 13.02% from the prior year.
• Accumulated Expenses was $1.2 million for Q2 2026 at BioCardia, down from $1.5 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $2.7 million in Q1 2024 and troughed at $1.2 million in Q2 2026.
• A 5-year average of $2.0 million and a median of $2.0 million in 2025 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses gained 28.75% in 2023 and tumbled 38.86% in 2026, its largest moves.
• Over 5 years, Accumulated Expenses stood at $2.2 million in 2022, then climbed by 6.19% to $2.4 million in 2023, then slumped by 34.97% to $1.6 million in 2024, then declined by 13.02% to $1.3 million in 2025, then slipped by 9.49% to $1.2 million in 2026.
• The last three Accumulated Expenses figures came in at $1.2 million (Q2 2026), $1.5 million (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.